Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-20-009297

Options or other derivatives

  • Chief Medical Officer acquired 133,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sachs Jessica Chief Medical Officer 2020-02-11 Grant or award · Stock Option +133,200 133,200 D
Loading xslF345X03/doc4.xml…